637 related articles for article (PubMed ID: 6474366)
1. [Comparative study of various rapid methods of determining fibrinogen transformation products in the diagnosis of intravascular coagulation and fibrinolysis].
Lychev VG; Momot AP; Cherkashin GV
Ter Arkh; 1984; 56(6):106-9. PubMed ID: 6474366
[TBL] [Abstract][Full Text] [Related]
2. Comparison of ethanol and protamine tests in demonstration of soluble fibrin and early products of fibrin degradation.
Konttinen YP; Kemppainen L; Turunen O
Thromb Diath Haemorrh; 1972 Dec; 28(3):342-50. PubMed ID: 4675265
[No Abstract] [Full Text] [Related]
3. Problems of diagnosis of disseminated intravascular coagulation (DIC).
Bowie EJ; Owen CA
Southeast Asian J Trop Med Public Health; 1979 Sep; 10(3):325-7. PubMed ID: 515796
[TBL] [Abstract][Full Text] [Related]
4. Comparisons of hemagglutination inhibition, staphylococcal clumping, and latex agglutination tests for canine fibrinolytic degradation products.
Chen JP; Williams TK; Legendre AM
Am J Vet Res; 1981 Dec; 42(12):2049-52. PubMed ID: 7340573
[TBL] [Abstract][Full Text] [Related]
5. [Paracoagulation tests in laboratory verification of intravascular coagulation. Comparative clinical evaluation of the SDPS test and of the ethanol test with serial dilution (SD ethanol test)].
Doni A; De Simonis SE; Pasquale G
Quad Sclavo Diagn; 1975 Mar; 11(1):159-75. PubMed ID: 1153697
[TBL] [Abstract][Full Text] [Related]
6. Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation.
Horan JT; Francis CW
Semin Thromb Hemost; 2001 Dec; 27(6):657-66. PubMed ID: 11740689
[TBL] [Abstract][Full Text] [Related]
7. [Molecular markers of hemostatic mechanisms--FDP-D Dimer].
Hada M
Rinsho Byori; 1989 Mar; 37(3):240-7. PubMed ID: 2664280
[No Abstract] [Full Text] [Related]
8. [Comparison of 2 tests of paracoagulation. Ethanol test and protamine sulfate test in the diagnosis of intravascular coagulation].
Conard J; Bogaty-Yver J; Samama M
Nouv Presse Med; 1974 Dec; 3(44):2639-41. PubMed ID: 4459852
[No Abstract] [Full Text] [Related]
9. Pathogenic role of intravascular coagulation in immune diseases.
Papilian M; Purice S; Niţă I; Tanaăseanu S
Med Interne; 1977; 15(4):341-7. PubMed ID: 594617
[TBL] [Abstract][Full Text] [Related]
10. [Biochemical studies in the postmortem diagnosis of the disseminated intravascular coagulation syndrome].
Avramenko EP; Zoroastrov OM; Galian SL; Gladyshev SP; Lotter MG
Sud Med Ekspert; 1998; 41(3):17-9. PubMed ID: 9703738
[TBL] [Abstract][Full Text] [Related]
11. [Fluctuation of plasma levels of fibrinogen degradation products, fibrin degradation products and total fibrin/fibrinogen degradation products in patients with DIC].
Isogai N; Kuroso K; Fujimaki M; Yorifuji H; Fukutake K
Rinsho Byori; 1993 Dec; 41(12):1349-52. PubMed ID: 8295346
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of 2 tests for determining lytic products of fibrin].
Chalini-Carreon F; Ortiz-Méndez VM; Olvera-Hidalgo C; Magaña-Pérez JA
Bol Med Hosp Infant Mex; 1983 Nov; 40(11):613-7. PubMed ID: 6651948
[No Abstract] [Full Text] [Related]
13. [Differential determination of fibrinogen degradation products in assessment of the stages of plasma consumption in patients with infection and liver cirrhosis].
Raschka C; Róka L
Leber Magen Darm; 1993 Jan; 23(1):31-4. PubMed ID: 8445974
[TBL] [Abstract][Full Text] [Related]
14. [Specificity and sensitivity of paracoagulation tests].
Litvinov RI; Voronina IE; Gabitov SE
Lab Delo; 1980; (11):662-6. PubMed ID: 6160297
[No Abstract] [Full Text] [Related]
15. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
16. [Objectivization of the protamine sulfate test through photometric measurements].
Thiele G; Fiedler H
Z Gesamte Inn Med; 1976 Jul; 31(14):542-4. PubMed ID: 960879
[TBL] [Abstract][Full Text] [Related]
17. Alterations in the coagulation and fibrinolysis system in pregnancy, labour and puerperium, with special reference to a possible transitory state of intravascular coagulation during labour.
Gilabert J; Aznar J; Parrilla JJ; Regañon E; Vila V; Estelles A
Thromb Haemost; 1978 Oct; 40(2):387-96. PubMed ID: 104402
[TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of a test for plasma fibrin/fibrinogen degradation products (FDP) based on monoclonal anti-FDP antibody technology: an application for the scoring system of the disseminated intravascular coagulation (DIC) diagnostic criteria].
Ito K; Wada H; Abe Y; Tomatsu H; Nishioka J; Nobori T
Rinsho Byori; 2003 Apr; 51(4):295-9. PubMed ID: 12747249
[TBL] [Abstract][Full Text] [Related]
19. [Determination of soluble complexes of fibrin monomers in plasma taking into consideration the fibrinogen level].
Ivanov EP; Tsvirko DG; Ivanov VE
Lab Delo; 1989; (12):38-43. PubMed ID: 2483201
[TBL] [Abstract][Full Text] [Related]
20. [Dynamics of blood coagulation and fibrinolysis and laboratory findings in disseminated intravascular coagulation].
Madoiwa S
Rinsho Ketsueki; 2010 Jan; 51(1):20-8. PubMed ID: 20134136
[No Abstract] [Full Text] [Related]
[Next] [New Search]
